Fulgent Genetics (FLGT) Price to Sales (2016 - 2026)

Fulgent Genetics has disclosed Price to Sales across 11 years of filings, most recently posting 6.61 for Q2 2026.

• In Q2 2026, Price to Sales fell 11.11% year-over-year to 6.61; the TTM figure through Jun 2026 stood at 2.34 (up 16.75% YoY), while the FY2025 annual figure was 2.53, up 25.92% from the prior year.
• Price to Sales came in at 6.61 for Q2 2026 at Fulgent Genetics, up from 6.45 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 2041.24 in Q4 2025 to a low of 5.91 in Q1 2022.
• Average Price to Sales over 5 years is 122.47, with a median of 9.37 recorded in 2023.
• Year-over-year, Price to Sales slumped 48.8% in 2024 and soared 27210.8% in 2025.
• Over 5 years, Price to Sales stood at 10.49 in 2022, then rose by 15.95% to 12.16 in 2023, then slumped by 38.53% to 7.47 in 2024, then surged by 27210.8% to 2041.24 in 2025, then slumped by 99.68% to 6.61 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 6.61 in Q2 2026, 6.45 in Q1 2026, and 2041.24 in Q4 2025.